Follow
Matthew J. Pianko, MD
Matthew J. Pianko, MD
Clinical Associate Professor, Div of Hematology/Oncology, Univ. of Michigan
Verified email at med.umich.edu
Title
Cited by
Cited by
Year
Harmful and protective roles of neutrophils in sepsis
LM Hoesel, TA Neff, SB Neff, JG Younger, EW Olle, H Gao, MJ Pianko, ...
Shock 24 (1), 40-47, 2005
1882005
Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease
MJ Pianko, E Terpos, GD Roodman, CR Divgi, S Zweegman, J Hillengass, ...
Clinical Cancer Research 20 (23), 5888-5897, 2014
872014
Immune checkpoint blockade for hematologic malignancies: a review
MJ Pianko, Y Liu, S Bagchi, AM Lesokhin
Stem cell investigation 4, 2017
852017
Ability of antioxidant liposomes to prevent acute and progressive pulmonary injury
LM Hoesel, MA Flierl, AD Niederbichler, D Rittirsch, SD McClintock, ...
Antioxidants & redox signaling 10 (5), 963-972, 2008
812008
Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition
MJ Pianko, SM Devlin, ER Littmann, A Chansakul, D Mastey, M Salcedo, ...
Blood advances 3 (13), 2040-2044, 2019
682019
C5a-blockade improves burn-induced cardiac dysfunction
LM Hoesel, AD Niederbichler, J Schaefer, KR Ipaktchi, H Gao, D Rittirsch, ...
The Journal of Immunology 178 (12), 7902-7910, 2007
632007
Distinguishing drug from disease by use of the hydrashift 2/4 daratumumab assay
KL Thoren, MJ Pianko, Y Maakaroun, CO Landgren, LV Ramanathan
The journal of applied laboratory medicine 3 (5), 857-863, 2019
372019
Immunotherapy of lymphoma and myeloma: facts and hopes
MJ Pianko, AJ Moskowitz, AM Lesokhin
Clinical Cancer Research 24 (5), 1002-1010, 2018
332018
Sustained minimal residual disease negativity in multiple myeloma is associated with stool butyrate and healthier plant-based diets
UA Shah, KH Maclachlan, A Derkach, M Salcedo, K Barnett, J Caple, ...
Clinical Cancer Research 28 (23), 5149-5155, 2022
282022
Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma
MJ Pianko, SA Funt, DB Page, D Cattry, EC Scott, SM Ansell, IM Borrello, ...
Leukemia & lymphoma 59 (1), 221-224, 2018
182018
Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study
H Mian, TM Wildes, R Vij, MJ Pianko, A Major, MA Fiala
Blood cancer journal 13 (1), 76, 2023
172023
Clinical development of PD-1 blockade in hematologic malignancies
MJ Pianko, AD Goldberg, AM Lesokhin
The Cancer Journal 24 (1), 31-35, 2018
172018
Optimal sequence of daratumumab and elotuzumab in relapsed and refractory multiple myeloma
E Hoylman, A Brown, AJ Perissinotti, BL Marini, M Pianko, JC Ye, ...
Leukemia & lymphoma 61 (3), 691-698, 2020
162020
Patterns of response to 200 mg linvoseltamab in patients with relapsed/refractory multiple myeloma: longer follow-up of the linker-MM1 study
S Jagannath, J Richter, MV Dhodapkar, JE Hoffman, HC Lee, ...
Blood 142, 4746, 2023
152023
Characterization of antigenic variants of hepatitis C virus in immune evasion
JH Wang, MJ Pianko, X Ke, A Herskovic, R Hershow, SJ Cotler, W Chen, ...
Virology Journal 8, 1-13, 2011
142011
Checkpoint blockade in melanoma patients with underlying chronic lymphocytic leukemia
JW Smithy, MJ Pianko, C Maher, MA Postow, AN Shoushtari, P Momtaz, ...
Journal of Immunotherapy 44 (1), 9-15, 2021
122021
TTI-622-01: A phase 1a/1b dose-escalation and expansion trial of TTI-622 in patients with advanced hematologic malignancies, including multiple myeloma.
K Patel, RZ Orlowski, K Doucette, M Maris, MJ Pianko, R Ramchandren, ...
Journal of Clinical Oncology 40 (16_suppl), TPS8071-TPS8071, 2022
92022
Host-microbe interactions and outcomes in multiple myeloma and hematopoietic stem cell transplantation
MJ Pianko, JL Golob
Cancer and Metastasis Reviews 41 (2), 367-382, 2022
92022
Abstract CT013: Safety and efficacy from the phase 1/2 first-in-human study of REGN5459, a BCMA× CD3 bispecific antibody with low CD3 affinity, in patients with relapsed …
A Suvannasankha, P Kapoor, MJ Pianko, J Richter, A D'Souza, ...
Cancer Research 83 (8_Supplement), CT013-CT013, 2023
82023
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma
N Bumma, J Richter, S Jagannath, HC Lee, JE Hoffman, ...
Journal of Clinical Oncology, JCO. 24.01008, 2024
72024
The system can't perform the operation now. Try again later.
Articles 1–20